Benitec Biopharma (BNTC) Short Interest Ratio & Short Volume → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free BNTC Stock Alerts $7.65 +0.10 (+1.32%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Benitec Biopharma Short Interest DataCurrent Short Interest56,100 sharesPrevious Short Interest98,500 sharesChange Vs. Previous Month-43.05%Dollar Volume Sold Short$496,485.00Short Interest Ratio0.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares9,370,000 sharesFloat Size2,230,000 sharesShort Percent of Float2.52%Today's Trading Volume41,354 sharesAverage Trading Volume39,277 sharesToday's Volume Vs. Average105% Short Selling Benitec Biopharma ? Sign up to receive the latest short interest report for Benitec Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNTC Short Interest Over TimeBNTC Days to Cover Over TimeBNTC Percentage of Float Shorted Over Time Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here Benitec Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202456,100 shares $496,485.00 -43.1%2.5%0.6 $8.85 4/30/202498,500 shares $832,325.00 +707.4%6.3%1.2 $8.45 4/15/202412,200 shares $59,902.00 +10.9%0.5%0.2 $4.91 3/31/202411,000 shares $57,750.00 +115.7%0.5%0.7 $5.25 3/15/20245,100 shares $26,010.00 -68.3%0.2%0.4 $5.10 2/29/202416,100 shares $78,085.00 +151.6%0.7%1.1 $4.85 Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,400 shares $18,432.00 -18.0%0.3%0.5 $2.88 1/31/20247,800 shares $21,918.00 +25.8%0.3%0.9 $2.81 1/15/20246,200 shares $18,166.00 -18.4%0.3%0.7 $2.93 12/31/20237,600 shares $24,548.00 -39.7%0.3%0.7 $3.23 12/15/202312,600 shares $42,462.00 +5.9%0.6%1.1 $3.37 11/30/202311,900 shares $37,842.00 -64.4%0.5%0.8 $3.18 11/15/202333,400 shares $125,918.00 -28.2%1.5%1.6 $3.77 10/31/202346,500 shares $167,865.00 -20.7%3.1%0.6 $3.61 10/15/202358,600 shares $199,826.00 -13.7%3.9%0.1 $3.41 9/30/202367,900 shares $205,173.43 -24.7%4.6%0.1 $3.02 9/15/202390,200 shares $285,032.00 -33.8%6.1%0.1 $3.16 8/31/2023136,300 shares $402,085.00 -51.1%9.2%0.2 $2.95 8/15/2023278,500 shares $749,165.00 +52.2%N/A0.4 $2.69 7/31/2023183,000 shares $563,640.00 -81.2%N/A0.3 $3.08 7/15/2023974,300 shares $223,991.57 -57.3%N/A0.3 $0.23 6/30/20232,280,000 shares $543,780.00 +1,061.5%N/A0.7 $0.24 6/15/2023196,300 shares $46,110.87 -22.8%N/A0.1 $0.23 5/31/2023254,300 shares $61,311.73 -19.9%N/A0.9 $0.24 5/15/2023317,400 shares $67,856.95 -5.8%N/A1.1 $0.21 4/30/2023337,000 shares $67,770.70 +77.9%N/A1 $0.20 4/15/2023189,400 shares $40,436.71 +73.4%N/A0.6 $0.21 3/31/2023109,200 shares $22,921.08 -45.0%N/A0.4 $0.21 3/15/2023198,700 shares $46,694.50 -52.5%N/A0.6 $0.24 2/28/2023418,700 shares $125,610.00 +101.1%N/A0.9 $0.30 2/15/2023208,200 shares $47,760.87 -3.6%N/A0.5 $0.23 1/31/2023215,900 shares $49,657.00 -1.7%N/A0.5 $0.23 1/15/2023219,600 shares $50,925.24 +109.9%N/A0.4 $0.23 12/30/2022104,600 shares $17,782.00 +245.2%N/A0.2 $0.17 12/15/202230,300 shares $4,545.00 -85.3%N/A0.1 $0.15 11/30/2022206,400 shares $42,312.00 +24.9%N/A0.3 $0.21 11/15/2022165,200 shares $28,596.12 -50.6%N/A0.3 $0.17 10/31/2022334,500 shares $58,637.85 +310.4%4.5%0.6 $0.18 10/15/202281,500 shares $19,486.65 -35.1%1.1%0.2 $0.24 9/30/2022125,600 shares $46,685.52 +187.4%2.1%0.4 $0.37This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 9/15/202243,700 shares $18,747.30 -87.7%0.6%0 $0.43 8/31/2022354,900 shares $262,519.53 +26.8%5.0%0.2 $0.74 8/15/2022279,900 shares $236,529.50 +353.7%4.0%0.1 $0.85 7/31/202261,700 shares $55,462.13 -40.1%0.9%0 $0.90 7/15/2022103,000 shares $110,210.00 -92.5%1.5%0 $1.07 6/30/20221,370,000 shares $1.59 million +13,738.4%19.5%0.6 $1.16 6/15/20229,900 shares $8,613.99 +23.8%0.1%0 $0.87 5/31/20228,000 shares $8,400.00 +281.0%0.1%0.3 $1.05 5/15/20222,100 shares $2,486.61 -56.3%0.0%0.1 $1.18 4/30/20224,800 shares $7,200.00 +166.7%0.1%0.2 $1.50 4/15/20221,800 shares $3,597.30 -67.9%0.0%0.1 $2.00 3/31/20225,600 shares $13,076.00 +75.0%0.1%0.2 $2.34 3/15/20223,200 shares $6,624.00 -70.1%0.1%0.1 $2.07 2/28/202210,700 shares $24,824.00 -17.1%0.2%0.3 $2.32 2/15/202212,900 shares $34,959.00 +84.3%0.2%0.4 $2.71 1/31/20227,000 shares $17,150.00 -77.4%0.1%0.2 $2.45 1/15/202231,000 shares $79,360.00 +121.4%0.4%0.8 $2.56 12/31/202114,000 shares $36,680.00 +17.7%0.2%0.4 $2.62 12/15/202111,900 shares $34,391.00 -13.1%0.2%0.3 $2.89 11/30/202113,700 shares $41,922.00 -9.3%0.2%0.1 $3.06 11/15/202115,100 shares $51,944.00 -29.8%0.2%0.1 $3.44 10/29/202121,500 shares $78,690.00 -21.3%0.3%0.2 $3.66 10/15/202127,300 shares $98,007.00 -1.1%0.4%0.2 $3.59 9/30/202127,600 shares $98,532.00 -78.0%0.4%0.2 $3.57 9/15/2021125,700 shares $487,716.00 -19.5%1.9%0.7 $3.88 8/31/2021156,200 shares $618,552.00 -25.1%3.9%1.5 $3.96 8/13/2021208,400 shares $827,348.00 +7.1%5.2%2 $3.97 7/30/2021194,600 shares $681,100.00 -2.5%4.9%0.7 $3.50 7/15/2021199,500 shares $758,100.00 -14.2%5.0%0.6 $3.80 6/30/2021232,400 shares $987,700.00 -18.1%5.8%0.6 $4.25 6/15/2021283,800 shares $1.25 million -19.8%7.1%0.4 $4.40 5/28/2021354,000 shares $1.67 million -6.4%8.9%0.1 $4.71 5/14/2021378,000 shares $1.77 million -0.2%9.5%0.1 $4.69 4/30/2021378,700 shares $1.61 million +35.0%12.0%0.1 $4.25 4/15/2021280,600 shares $1.46 million +21.0%7.8%0.1 $5.21 3/31/2021232,000 shares $997,600.00 +422.5%6.0%0.1 $4.30 3/15/202144,400 shares $146,076.00 +45.6%1.0%0 $3.29 2/26/202130,500 shares $106,902.50 -13.4%0.7%0.1 $3.51 2/12/202135,200 shares $174,592.00 +9.7%N/A0.1 $4.96 1/29/202132,100 shares $130,005.00 +79.3%2.3%0.1 $4.05 1/15/202117,900 shares $65,335.00 -57.8%1.3%0 $3.65 12/31/202042,400 shares $134,832.00 +480.8%3.2%0.1 $3.18 12/15/20207,300 shares $19,856.00 -84.9%0.5%0 $2.72 11/30/202048,400 shares $142,296.00 +44.9%3.6%0.1 $2.94 11/15/202033,400 shares $96,038.36 +475.9%2.5%0.1 $2.88 10/30/20205,800 shares $15,950.00 -68.0%0.4%0.1 $2.75 10/15/202018,100 shares $52,490.00 -54.6%1.4%0.2 $2.90 9/30/202039,900 shares $250,572.00 +100.5%3.6%0.6 $6.28 9/15/202019,900 shares $118,846.78 +19.9%1.3%1.5 $5.97 8/31/202016,600 shares $115,536.00 +1,409.1%1.0%0.6 $6.96This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 8/14/20201,100 shares $9,042.00 -79.6%0.1%0 $8.22 7/31/20205,400 shares $38,556.00 +3.9%0.3%0.2 $7.14 7/15/20205,200 shares $36,244.00 +44.4%0.3%0.2 $6.97 6/30/20203,600 shares $28,728.00 +414.3%0.2%0.1 $7.98 6/15/2020700 shares $5,656.00 -82.9%0.0%0 $8.08 5/29/20204,100 shares $28,987.00 -65.6%0.3%0.1 $7.07 5/15/202011,900 shares $99,484.00 +271.9%0.8%0.2 $8.36 4/30/20203,200 shares $29,120.00 +10.3%0.0%0 $9.10 4/15/20202,900 shares $15,704.37 -71.3%N/A0 $5.42 3/31/202010,100 shares $110,393.00 +405.0%N/A0.1 $10.93 3/13/20202,000 shares $8,800.00 -13.0%N/A0.1 $4.40 2/28/20202,300 shares $7,291.00 -32.4%N/A0 $3.17 2/14/20203,400 shares $14,144.00 +240.0%N/A0 $4.16 1/31/20201,000 shares $4,490.00 -16.7%N/A0 $4.49 1/15/20201,200 shares $6,300.00 -87.0%N/A0.1 $5.25 12/31/20199,200 shares $42,780.00 +95.7%N/A0.6 $4.65 BNTC Short Interest - Frequently Asked Questions What is Benitec Biopharma's current short interest? Short interest is the volume of Benitec Biopharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 56,100 shares of BNTC short. 2.52% of Benitec Biopharma's shares are currently sold short. Learn More on Benitec Biopharma's current short interest. What is a good short interest ratio for Benitec Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTC shares currently have a short interest ratio of 1.0. Learn More on Benitec Biopharma's short interest ratio. Which institutional investors are shorting Benitec Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Benitec Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Benitec Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.52% of Benitec Biopharma's floating shares are currently sold short. Is Benitec Biopharma's short interest increasing or decreasing? Benitec Biopharma saw a decline in short interest in May. As of May 15th, there was short interest totaling 56,100 shares, a decline of 43.0% from the previous total of 98,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Benitec Biopharma's float size? Benitec Biopharma currently has issued a total of 9,370,000 shares. Some of Benitec Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Benitec Biopharma currently has a public float of 2,230,000 shares. How does Benitec Biopharma's short interest compare to its competitors? 2.52% of Benitec Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Benitec Biopharma: Skye Bioscience, Inc. (0.13%), Nkarta, Inc. (16.27%), Nanobiotix S.A. (0.12%), UroGen Pharma Ltd. (19.06%), Atea Pharmaceuticals, Inc. (2.53%), Ventyx Biosciences, Inc. (16.38%), Kamada Ltd. (0.11%), ADC Therapeutics SA (1.36%), Vanda Pharmaceuticals Inc. (5.08%), Neoleukin Therapeutics, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Benitec Biopharma stock? Short selling BNTC is an investing strategy that aims to generate trading profit from Benitec Biopharma as its price is falling. BNTC shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Benitec Biopharma? A short squeeze for Benitec Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTC, which in turn drives the price of the stock up even further. How often is Benitec Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTC, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SKYE Short Interest Data NKTX Short Interest Data NBTX Short Interest Data URGN Short Interest Data AVIR Short Interest Data VTYX Short Interest Data KMDA Short Interest Data ADCT Short Interest Data VNDA Short Interest Data NLTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNTC) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDon’t buy a single NVIDIA share before you see this...Behind the MarketsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace“Financial tsunami is coming to America”Porter & CompanyNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.